This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Clovis Oncology Inc (CLVS)

NASDAQ: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Cash and Equivalents 482.68M 323.23M 144.10M 138.24M
Receivables 0.00 3.87M 0.00 0.00
Inventories 0.00 0.00 0.00 0.00
Other Current Assets 4.73M 0.00 659.00K 247.00K
Total Current Assets 491.17M 328.60M 144.87M 141.52M
Property, Plant & Equipment, Gross 3.79M 1.68M 1.59M 2.17M
Accumulated Depreciation & Depletion 1.08M 728.00K 508.00K 274.00K
Property, Plant & Equipment, Net 2.72M 955.00K 1.08M 1.90M
Intangibles 212.90M 244.52M 0.00 0.00
Other Non-Current Assets 13.36M 755.00K 38.00K 34.00K
Total Non-Current Assets 295.03M 321.04M 1.12M 1.93M
Liabilities & Shareholder Equity
Total Assets 786.21M 649.64M 145.99M 143.44M
Accounts Payable 2.92M 4.42M 2.30M 3.04M
Short Term Debt 0.00 0.00 0.00 0.00
Other Current Liabilities 411.00K 0.00 0.00 0.00
Total Current Liabilities 47.77M 20.95M 12.16M 11.00M
Long Term Debt 287.50M 0.00 0.00 0.00
Deferred Income Taxes 66.85M 74.96M 0.00 0.00
Other Non-Current Liabilities 52.45M 55.84M 338.00K 656.00K
Minority Interest 0.00 0.00 0.00 0.00
Total Non-Current Liabilities 406.80M 130.80M 338.00K 656.00K
Total Liabilities 454.58M 151.75M 12.50M 11.65M
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 331.63M 497.89M 133.50M 131.79M
Common Par 34.00K 34.00K 26.00K 22.00K
Additional Paid In Capital 785.09M 762.17M 317.90M 242.22M
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -429.04M -269.01M -184.48M -110.50M
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -24.45M 4.70M 53.00K 49.00K
Total Capitalization 619.13M 497.89M 133.50M 131.79M
Total Equity 331.63M 497.89M 133.50M 131.79M
Total Liabilities & Stock Equity 786.21M 649.64M 145.99M 143.44M
Total Common Shares Outstanding 33.98M 33.90M 26.21M 22.38M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 33.89M 28.67M 24.92M 3.85M
Diluted Weighted Shares Outstanding 33.89M 28.67M 24.92M 3.85M
Number of Employees 136 74 61 57
Number of Part-Time Employees 0 0 0 0

CLVS Clovis Oncology Inc

Chart of CLVS

Analysts Ratings for CLVS

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 3 3 3
Moderate Buy 0 0 0 0
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

CLVS Chatter

Select the service that is right for you!

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Chris Versace, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Daily Swing Trade

Master swing trader Alan Farley uses his sophisticated software screens to review thousands of stocks each day for you, to find just the handful that meet his demanding criteria.

Product Features:
  • Daily commentary and coaching on swing trading
  • Technical charts and analysis
Top Rated Stocks Top Rated Funds Top Rated ETFs